Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Nootkatone Essential Oil-Encapsulated Lipid Nanoparticles Interaction with Rat Cardiomyoblast (H9c2) Cells

Nootkatone Essential Oil-Encapsulated Lipid Nanoparticles Interaction with Rat Cardiomyoblast... Introduction: This study aimed to develop biocompatible lipid-mediated nootkatone (NK) essential oil-loaded solid lipid nanoparticles (SLNs) using Gelucire® 44/14 and to evaluate their interaction with rat cardiomyoblast (H9c2) cells.Methods: Solid lipid-mediated NK essential oil-loaded SLNs were prepared using an ethanol injection technique, and the proper exploration of various physicochemical characteristics and cellular investigations was systematically performed. The particle size, polydispersity index, zeta potential, drug loading, entrapment efficiency, in vitro drug release, cellular uptake, stability, and cytotoxicity were evaluated, and the hemolytic effects were studied.Results: The prepared SLNs were found to be in the nano-size range <200 nm and had a negative surface charge with the desired monodispersity. The NK-loaded SLNs showed (1.05% ± 0.19%) drug loading with 74.51% ± 6.64% loading efficiency with almost complete release within 24 hours. SLNs showed a high intracellular uptake within 1 hour. Stability study showed that the formulation found to be stable till 30 days. Pretreatment with nontoxic concentrations of NK-loaded SLNs (1.953 μg/mL) significantly reduced cytotoxicity in H9c2 cells induced by doxorubicin and showed a negligible hemolytic effect.Conclusion: Hence, it can be concluded that solid lipid-mediated NK essential-oil-loaded SLNs enhanced the stability, safety, and potency of NK, and it may be a promising approach for the prevention and treatment of cardiovascular diseases. It can be further explored in preclinical and clinical settings to evaluate its mechanism of action. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Applied In Vitro Toxicology Mary Ann Liebert

Nootkatone Essential Oil-Encapsulated Lipid Nanoparticles Interaction with Rat Cardiomyoblast (H9c2) Cells

Nootkatone Essential Oil-Encapsulated Lipid Nanoparticles Interaction with Rat Cardiomyoblast (H9c2) Cells

Applied In Vitro Toxicology , Volume 8 (1): 10 – Mar 1, 2022

Abstract

Introduction: This study aimed to develop biocompatible lipid-mediated nootkatone (NK) essential oil-loaded solid lipid nanoparticles (SLNs) using Gelucire® 44/14 and to evaluate their interaction with rat cardiomyoblast (H9c2) cells.Methods: Solid lipid-mediated NK essential oil-loaded SLNs were prepared using an ethanol injection technique, and the proper exploration of various physicochemical characteristics and cellular investigations was systematically performed. The particle size, polydispersity index, zeta potential, drug loading, entrapment efficiency, in vitro drug release, cellular uptake, stability, and cytotoxicity were evaluated, and the hemolytic effects were studied.Results: The prepared SLNs were found to be in the nano-size range <200 nm and had a negative surface charge with the desired monodispersity. The NK-loaded SLNs showed (1.05% ± 0.19%) drug loading with 74.51% ± 6.64% loading efficiency with almost complete release within 24 hours. SLNs showed a high intracellular uptake within 1 hour. Stability study showed that the formulation found to be stable till 30 days. Pretreatment with nontoxic concentrations of NK-loaded SLNs (1.953 μg/mL) significantly reduced cytotoxicity in H9c2 cells induced by doxorubicin and showed a negligible hemolytic effect.Conclusion: Hence, it can be concluded that solid lipid-mediated NK essential-oil-loaded SLNs enhanced the stability, safety, and potency of NK, and it may be a promising approach for the prevention and treatment of cardiovascular diseases. It can be further explored in preclinical and clinical settings to evaluate its mechanism of action.

Loading next page...
 
/lp/mary-ann-liebert/nootkatone-essential-oil-encapsulated-lipid-nanoparticles-interaction-C8j2vKVqT6
Publisher
Mary Ann Liebert
Copyright
Copyright 2022, Mary Ann Liebert, Inc., publishers
ISSN
2332-1512
eISSN
2332-1539
DOI
10.1089/aivt.2021.0019
Publisher site
See Article on Publisher Site

Abstract

Introduction: This study aimed to develop biocompatible lipid-mediated nootkatone (NK) essential oil-loaded solid lipid nanoparticles (SLNs) using Gelucire® 44/14 and to evaluate their interaction with rat cardiomyoblast (H9c2) cells.Methods: Solid lipid-mediated NK essential oil-loaded SLNs were prepared using an ethanol injection technique, and the proper exploration of various physicochemical characteristics and cellular investigations was systematically performed. The particle size, polydispersity index, zeta potential, drug loading, entrapment efficiency, in vitro drug release, cellular uptake, stability, and cytotoxicity were evaluated, and the hemolytic effects were studied.Results: The prepared SLNs were found to be in the nano-size range <200 nm and had a negative surface charge with the desired monodispersity. The NK-loaded SLNs showed (1.05% ± 0.19%) drug loading with 74.51% ± 6.64% loading efficiency with almost complete release within 24 hours. SLNs showed a high intracellular uptake within 1 hour. Stability study showed that the formulation found to be stable till 30 days. Pretreatment with nontoxic concentrations of NK-loaded SLNs (1.953 μg/mL) significantly reduced cytotoxicity in H9c2 cells induced by doxorubicin and showed a negligible hemolytic effect.Conclusion: Hence, it can be concluded that solid lipid-mediated NK essential-oil-loaded SLNs enhanced the stability, safety, and potency of NK, and it may be a promising approach for the prevention and treatment of cardiovascular diseases. It can be further explored in preclinical and clinical settings to evaluate its mechanism of action.

Journal

Applied In Vitro ToxicologyMary Ann Liebert

Published: Mar 1, 2022

There are no references for this article.